⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
REGENERNON PHARMACEUTICALS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 14, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
globenewswire.com
REGN
INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. (REGN) Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit
prnewswire.com
REGN
Regeneron Pharmaceuticals, Inc. (REGN) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Advises Shareholders of Class Action Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
REGN Court Alert: Regeneron Investors Seeking to Recover Losses in Securities Fraud Class Action are Notified to Contact BFA Law before September 14 Deadline
globenewswire.com
REGN
Join Class Action to Recover Losses from Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
REGN
Investors in Regeneron Pharmaceuticals, Inc. (REGN): Protect Your Rights - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN